Psychemedics Free Cash Flow 2010-2024 | PMD
Psychemedics free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Psychemedics Annual Free Cash Flow |
| 2023 |
-1.64 |
| 2022 |
4.70 |
| 2021 |
0.23 |
| 2020 |
-4.93 |
| 2019 |
2.63 |
| 2018 |
6.74 |
| 2017 |
7.95 |
| 2016 |
7.26 |
| 2015 |
2.83 |
| 2014 |
-3.11 |
| 2013 |
4.42 |
| 2012 |
0.87 |
| 2011 |
2.58 |
| 2010 |
2.48 |
| 2009 |
2.36 |
| Psychemedics Quarterly Free Cash Flow |
| 2024-03-31 |
-0.47 |
| 2023-12-31 |
-1.64 |
| 2023-09-30 |
-2.17 |
| 2023-06-30 |
-1.20 |
| 2023-03-31 |
-0.25 |
| 2022-12-31 |
4.70 |
| 2022-09-30 |
2.94 |
| 2022-06-30 |
0.65 |
| 2022-03-31 |
0.34 |
| 2021-12-31 |
0.23 |
| 2021-09-30 |
-0.22 |
| 2021-06-30 |
0.22 |
| 2021-03-31 |
-0.42 |
| 2020-12-31 |
-4.93 |
| 2020-09-30 |
-5.96 |
| 2020-06-30 |
-4.26 |
| 2020-03-31 |
-0.67 |
| 2019-12-31 |
2.63 |
| 2019-09-30 |
2.47 |
| 2019-06-30 |
1.53 |
| 2019-03-31 |
0.35 |
| 2018-12-31 |
6.74 |
| 2018-09-30 |
3.23 |
| 2018-06-30 |
3.32 |
| 2018-03-31 |
1.26 |
| 2017-12-31 |
7.95 |
| 2017-09-30 |
6.71 |
| 2017-06-30 |
3.09 |
| 2017-03-31 |
4.25 |
| 2016-12-31 |
7.26 |
| 2016-09-30 |
4.89 |
| 2016-06-30 |
1.74 |
| 2016-03-31 |
-0.02 |
| 2015-12-31 |
2.83 |
| 2015-09-30 |
0.96 |
| 2015-06-30 |
1.16 |
| 2015-03-31 |
0.35 |
| 2014-12-31 |
-3.11 |
| 2014-09-30 |
-5.04 |
| 2014-06-30 |
-5.59 |
| 2014-03-31 |
-1.78 |
| 2013-12-31 |
4.42 |
| 2013-09-30 |
3.02 |
| 2013-06-30 |
1.83 |
| 2013-03-31 |
0.46 |
| 2012-12-31 |
0.87 |
| 2012-09-30 |
1.30 |
| 2012-06-30 |
1.16 |
| 2012-03-31 |
0.10 |
| 2011-12-31 |
2.58 |
| 2011-09-30 |
-0.13 |
| 2011-06-30 |
0.31 |
| 2011-03-31 |
-0.32 |
| 2010-12-31 |
2.48 |
| 2010-09-30 |
0.97 |
| 2010-06-30 |
0.14 |
| 2010-03-31 |
-0.02 |
| 2009-12-31 |
2.36 |
| 2009-09-30 |
0.47 |
| 2009-06-30 |
0.18 |
| 2009-03-31 |
-0.18 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.015B |
$0.022B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
